Related Experiment Videos

Simple screening techniques for the detection of hypercoagulation. A study of 53 children suffering from familial

Haemostasis
|January 1, 1984
PubMed

Insights

New screening methods for hypercoagulability in children with familial hypercholesterolemia are introduced. Thrombokinetics (TKG) and a new quotient parameter show promise in detecting clotting risks, linked to factor VII activity.

Area of Science:

  • Pediatric Cardiology
  • Hematology
  • Clinical Chemistry

Background:

  • Familial hypercholesterolemia (FH) is a genetic disorder leading to high cholesterol levels.
  • Children with FH have an increased risk of cardiovascular events, potentially linked to hypercoagulability.
  • Early detection of hypercoagulability in pediatric FH patients is crucial for risk stratification.

Purpose of the Study:

  • To present novel screening techniques for detecting hypercoagulability in children with FH.
  • To evaluate the utility of Thrombokinetics (TKG) and a new quotient parameter.
  • To compare these new methods with conventional coagulation tests.

Main Methods:

  • Development and application of Thrombokinetics (TKG) assay.
  • Introduction and calculation of a novel quotient parameter.
  • Comparative analysis of new techniques against established coagulation assays.

Main Results:

  • The study presents new screening techniques, including TKG and a quotient.
  • A pilot study demonstrated a link between an elevated quotient and the activated stage of factor VII.
  • Critical preparation of a normal pool is necessary for defining reliable normal values.

Conclusions:

  • Novel screening techniques, including TKG and a quotient, show potential for identifying hypercoagulability in pediatric FH.
  • The quotient parameter appears to correlate with factor VII activation.
  • Standardized normal values require a carefully prepared normal pool for accurate clinical application.

Related Concept Videos